REPCF
RepliCel Life Sciences Inc.

Simon Ma is a Chartered Professional Accountant and has extensive experience with private companies as well as public companies in the resource sector. He graduated from the University of British Columbia in 1987 and obtained a degree of Bachelor of Arts in Economics after which he worked in the industry as a Controller to 1990. He started articling in 1990 and qualified as a Chartered Accountant in 1994. Simon Ma has been a sole public practitioner since 1997 and is practicing under the name of Simon S. Ma Corporation. He is concurrently serving as chief financial officer of several public companies listed on the TSX Venture Exchange or Canadian Securities Exchange. These companies include North American Potash Inc., Gem International Resources Inc., E-Energy Ventures Inc., United Coal Holdings Ltd., Quanta Resources Inc., and DGS Minerals Inc. He has also been working with RepliCel since June of 2016.

Rolf brings to Shield over 30 years of international pharmaceutical experience, having served in several senior roles in the industry, most recently twelve years with Amgen as Senior Vice President of Commercial Operations for the United States, and before that as SVP International and Europe. He started his pharmaceutical career at Eli Lilly as a sales representative, progressing to senior positions including President of Latin America Operations and General Manager in Germany. Rolf holds an MBA from the University of North Carolina and a master’s degree from the University of Cologne and is Adjunct Professor at UNC Kenan-Flagler Business School. Member of the Nomination Committee and the Remuneration Committee.

Mr. Lowry is a director and consultant with Pkarma Ltd. His work includes the use of lean methodology and customer focused design, and the utilization of objective data to drive strategy and programs. Mr. Lowry's CV includes consulting and operational management roles as General Manager of the Greenlane Heart Unit, leading Auckland Orthopedics, and the development and operational management of a number of joint-ventures that leverage intellectual property across a range of clinical and commercial settings. Mr. Lowry graduated with a Bachelor of Management Studies from the University of Waikato, and is a Chartered Accountant. He is a long-term shareholder of RepliCel and served as an advisor to the Company on its transaction with YOFOTO prior to being elected to the RepliCel Board of Directors in late 2018.

Mr. Schutte is the Chief Technology Officer with MainPointe Pharmaceuticals in Louisville Kentucky. Additionally, he is president and sole proprietor of two oil industry related companies, Nolan Olbohrung LLC and Valence Oil LLC. Investment-minded and accomplished, his current CV also includes the management of several private investment accounts. Mr. Schutte began his career in pharmaceuticals with US based, Gerimed Inc. as a VBA Programmer. Gerimed Inc. serviced independent pharmacies serving long-term care and home care patients. He has been a shareholder of RepliCel since early 2017 and served as an advisor to the Company prior to being elected to the RepliCel Board of Directors in late 2018.